Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126110942 | 12611094 | 2 | F | 20160722 | 20160801 | 20160801 | EXP | LB-SA-2016SA136119 | AVENTIS | 24.00 | YR | A | F | Y | 0.00000 | 20160801 | CN | LB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126110942 | 12611094 | 1 | PS | CEREZYME | IMIGLUCERASE | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 20367 | POWDER FOR SOLUTION FOR INFUSION | ||||||||
| 126110942 | 12611094 | 2 | SS | CEREZYME | IMIGLUCERASE | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 20367 | POWDER FOR SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126110942 | 12611094 | 1 | Gaucher's disease type I |
| 126110942 | 12611094 | 2 | Gaucher's disease type I |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126110942 | 12611094 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126110942 | 12611094 | Depressed level of consciousness | |
| 126110942 | 12611094 | Intentional product misuse | |
| 126110942 | 12611094 | Nervous system disorder | |
| 126110942 | 12611094 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |